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Purpose: To describe a case of fungal endophthalmitis secondary to Curvularia after cataract surgery.
Observations: This case showed delayed and recalcitrant fungal endophthalmitis secondary to Curvularia
despite treatment with pars plana vitrectomy, intravitreal antifungal therapy, and systemic antifungals.
Conclusions and importance: Curvularia-associated endophthalmitis should be considered in the differ-
ential diagnosis of delayed post-cataract endophthalmitis, especially in tropical or subtropical
geographical areas. Awareness and early identiﬁcation, timely removal of the nidi of sequestration, and
prolonged antifungal treatments are important for the eradication of Curvularia-associated
endophthalmitis.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Curvularia is a dematiaceous ﬁlamentous fungus, which is
ubiquitous in soil and plants, especially in warm climates [1,2].
Endophthalmitis associated with Curvularia is a rare event. We
describe a case of delayed and recalcitrant fungal endophthalmitis
secondary to Curvularia infection.2. Case report
A 78-year old female presented with a one-week history of
painless red eye with decreased best corrected visual acuity (BCVA)
in the right eye (OD). There were no known inciting factors; how-
ever, she had uncomplicated cataract surgery in the affected eye
three years prior. Her past medical history was signiﬁcant for hy-
pertension, hyperlipidemia, and rheumatoid arthritis (RA), and her
family history was otherwise non-contributory.
On examination, BCVA was 20/50 OD with an intraocular pres-
sure (IOP) of 23mmHg. On the anterior segment examination, there
were 1þ cells and ﬂare in the anterior chamber without keratic
precipitate or hypopyon. The posterior chamber intraocular lens
was centered and clear with no deposits or posterior capsule7760 France Ave S, Minneap-
(D.R.P. Almeida).
Inc. This is an open access article uopacity (PCO). On dilated fundus examination, there was no vitritis
or cystoid macular edema. Slit lamp and fundus exam OS was
normal. She was treated with topical diﬂuprednate four times per
day OD.
One month later, BCVA declined to 20/400 with increased
anterior uveitis. Fibrin deposits on the posterior capsule were
noted, as well as 2þ vitritis (Fig. 1A). B-scan ultrasound showed
vitreous opacities with diffuse thickening of the retina and
choroidal layers posteriorly (Fig. 2). The patient was initially treated
with oral prednisone 60 mg daily for two weeks for suspected RA-
associated scleritis by an outside provider, and endophthalmitis
was not initially considered given the time delay since cataract
surgery.
The patient had counting ﬁngers vision without any pain just
two weeks later. There was 4þ cell and ﬂare in the anterior
chamber, but without a hypopyon. There were new focal white
clumps of the posterior capsule. A 23-gauge pars plana vitrectomy
was performed for presumed chronic endophthalmitis and the
vitreous specimen was sent to microbiology for culture. During the
procedure, intravitreal amphotericin (5 mg/0.1 cc), vancomycin
(1 mg/0.1 cc), and ceftazidime (2.25 mg/0.1 cc) were administered.
The patient was also started on oral voriconazole 200 mg twice per
day. Vitreous cultures identiﬁed fungal Curvularia species.
Four weeks after surgery, the vision improved to 20/250. Repeat
intravitreal amphotericin (5 mg/0.1 cc) was performed due to
persistent inﬂammation. Oral voriconazole was continued and
topical prednisolone acetate 1% drops four times daily wasnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Slit-lamp photographs of the affected right eye. 1A - initial visit with signiﬁcant
posterior capsular opaciﬁcation, ﬁbrin deposits on the posterior capsule. 1B - 6-week
follow-up with extensive ﬁbrin throughout the anterior chamber.
Fig. 2. B-scan ultrasound at one month follow-up after the initial presentation. 2A -
scattered vitreous opacities consistent with dense vitritis. 2B - diffuse thickening of
retina and the choroidal layers posteriorly (measuring approximately 2.2 mm).
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moderate epiretinal membrane OD developed which was treated
with vitrectomy and membrane peeling.
At one month follow-up, the BCVA worsened to 20/250 with a
low IOP of 5 mmHg OD. A 360-degree iris neovascularization was
seen. A laser posterior capsulotomy was performed for the dense
PCO OD. The PCO contained small foci of hypo-pigmented deposits.
She developed a hypotony maculopathy one month later with
BCVA of 20/1250 (Fig. 3). A posterior subtenons injection of
triamcinolone acetonide (40 mg) was done to increase the IOP. Six
weeks later, the BCVAwas worse with a light perception vision and
an IOP of 4 mmHg. The AC showed extensive and dense ﬁbrin
(Fig. 1B). She had a persistent vitritis with extensive thickening and
elevation of the retina/choroid layer (Fig. 4). Vitreous tap and repeat
intravitreal Amphotericin (5 mg) was administered.
On the subsequent one week follow-up, the vitreous appeared
clear and the choroidal elevation resolved; however, the 360-
degree extensive thickening of the retina/choroid layer persisted
and a shallow exudative retinal detachment developed (Fig. 4).
Intravitreal Amphotericin (5 mg/0.1 cc) was repeated. As retinal
detachment was threatening the macula, pars plana vitrectomy
with vitreous biopsy, scleral buckling, intraocular lens removal,
intravitreal voriconazole (100 mg/0.1 cc) and oil insertion was done.
The vitreous biopsy was once again positive for Curvularia species.
One-week post-operatively, her BCVA improved to hand motion
with an IOP of 15 mmHg. The infectious disease service was con-
sulted and she was admitted to hospital for intravenous vor-
iconazole 100 mg daily for ﬁve days. She was placed on long-term
oral voriconazole 300 mg twice per day and has been stable withhand motion vision since then. A written consent was obtained
from the patient for publication of personal information (including
medical record details).
3. Discussion
Endophthalmitis is a devastating diagnosis and bacteria are the
main causes [3]. Only a small portion of cases is thought to be
associated with fungal infections [4]. Curvularia, which lives in the
soil and on plants, is found in tropical climates, and is spread by
airborne spores [5]. To date, there are only eleven reported cases of
endophthalmitis secondary to Curvularia. [6e10] Among those
cases, eight patients had a preceding history of cataract surgery
[6,8e10], while four had a previous history of trauma [7,9,10]. Our
case is unique due to its delayed and recalcitrant course.
Among all the cases with a preceding history of cataract surgery,
the interval between surgery and initial symptom was between 1
and 5 months [6,8e10]. In our case, the interval from surgery to
initial symptom was three years, an unusually delayed-onset
postoperative endophthalmitis associated with Curvularia.
In the literature, only two patients retained vision of 20/30 after
aggressive antifungal treatment for Curvularia-associated endoph-
thalmitis [8,9]. Our patient most recently had hand motion vision,
despite aggressive anti-fungal therapy both locally and systemi-
cally, as well as multiple surgeries. Hence, endophthalmitis due to
Curvularia should be considered in the differential diagnosis of
endophthalmitis post cataract surgery, especially in tropical or
subtropical areas.
In cases of endophthalmitis caused by Curvularia, the correct
diagnosis can be challenging for those who have a preceding
cataract surgery. This may be related to its delayed-onset, or lack of
knowledge about the typical clinical presentations of this condition
due to its rarity. However, in the previous cases of Curvularia-
Fig. 3. Optical coherence tomography at two months following membrane peeling surgery, complicated by hypotony with choroidal folds in the macula.
Fig. 4. B-scan ultrasound at 6-week follow-up after posterior subtenon injection of
triamcinolone acetonide (A) and after the third intravitreal injection of Amphotericin B
(B). A. Vitreous opacities with extensive thickening of the retina/choroid. B. Diminished
vitreous opacities with extensive thickening of the retina/choroid layer (2.1 mm in
greatest thickness), and a shallow elevation of retina at 4 o’clock just posterior to
equator).
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described in 4 out of 8 patients who had an inciting event of
cataract surgery [8,10]. In our case, the PCO was also seen and may
be an important sign to identify, or at least suspect, a diagnosis of
endophthalmitis related to Curvularia.In this case, the use of steroids (topical, oral, and periocular)
without the concurrent anti-fungal coverage might have led to the
activation or worsening of the underlying endophthalmitis sec-
ondary to Curvularia. Our case shows recalcitrant Curvularia
endophthalmitis despite treatment with pars plana vitrectomy,
intravitreal antifungal therapy, and systemic antifungals. It was
likely that the intraocular lens and lens capsule were the nidi of the
Curvularia infection, which should have been removed earlier on.
Oral administration of voriconazole can achieve an intravitreal
concentration of 0.81 mg/ml, which is higher than 90% of minimum
inhibitory concentration for Curvularia [11]. Hence, systemic vor-
iconazole is a good option for Curvularia endophthalmitis. Oral
administration of voriconazole 200 mg every 12 hours should be
started when fungal etiology ﬁrst suspected [12].4. Conclusions
We describe a case of delayed and recalcitrant fungal endoph-
thalmitis secondary to Curvularia despite treatment with pars plana
vitrectomy, intravitreal antifungal therapy, and systemic antifun-
gals. Curvularia-associated endophthalmitis should be considered
in the differential diagnosis of delayed post-cataract endoph-
thalmitis, especially in tropical or subtropical geographical areas.
Awareness and early identiﬁcation, timely removal of the nidi of
sequestration, and prolonged antifungal treatments are important
for the eradication of Curvularia-associated endophthalmitis.Statement
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